Pulmonary embolism symptoms include sudden shortness of breath, sharp chest pain that worsens with a deep breath, a fast heart rate, and coughing up blood. These occur when a clot blocks blood flow in a lung artery. Symptoms can appear within seconds to hours of the blockage and range from subtle to fatal. Recognizing the pattern matters because roughly a quarter of pulmonary embolisms first announce themselves as sudden death.
This explainer goes deeper than a symptom list. It covers why the signs appear, how often each one shows up, which presentations fool clinicians, and what to do with a real suspicion. You will also see where the standard thresholds come from and where they disagree.
The plumbing problem behind every symptom
A pulmonary embolism is a blockage in a pulmonary artery, the vessel carrying blood from the right side of the heart to the lungs for oxygen. More than 95 percent of the time the blocker is a thrombus, a blood clot that formed somewhere else and traveled. Most originate in the deep veins of the legs or pelvis, a condition called deep vein thrombosis.
The symptoms are not random. They map onto three consequences of the blockage. First, the blocked vessel starves a patch of lung tissue of blood, producing pain and sometimes infarction, meaning tissue death. Second, blood backs up behind the obstruction, raising pressure in the right ventricle, the heart chamber that pumps into the lungs. Third, gas exchange fails because blood bypasses or cannot reach ventilated lung units.
That backup explains the signature findings. Right ventricular strain causes a fast heart rate and, in severe cases, low blood pressure. Impaired gas exchange lowers blood oxygen and drives rapid breathing. Clot breakdown products and lung inflammation can cause low-grade fever. Coughing up blood tends to appear later, when the blocked segment infarcts.
Size and location govern severity more than clot burden alone. A small clot lodged at a vessel bifurcation can be deadlier than a larger one in a peripheral branch. This is why symptom intensity is a poor proxy for danger, and why imaging, not symptom counting, confirms diagnosis.
Quantified context: how common, how deadly, how often each sign appears
Pulmonary embolism is the third most common acute cardiovascular emergency after heart attack and stroke. Population studies in the United States put annual incidence at roughly 60 to 120 cases per 100,000 people, with higher rates in adults over 60. It remains a leading preventable cause of hospital death.
Symptom frequencies are well characterized in cohort data. Dyspnea, or shortness of breath, appears in about 70 to 80 percent of confirmed cases. Chest pain of some kind appears in roughly half. Tachycardia, generally defined as a heart rate above 100 beats per minute, appears in about 40 to 50 percent. Cough appears in about 20 percent. Hemoptysis, coughing up blood, appears in only about 10 to 15 percent, yet it is strongly associated with infarction.
The mortality figures carry the main message. Untreated pulmonary embolism carries a mortality of roughly 25 to 30 percent in older series. With treatment, mortality falls to about 2 to 8 percent overall. The gap is widest in massive embolism, where the clot causes sustained low blood pressure or cardiac arrest.
| Presentation | Typical symptoms | Approximate share of cases | Early mortality risk |
|---|---|---|---|
| Massive (high-risk) | Shock, fainting, low blood pressure | 5 percent | Highest, often above 15 percent |
| Submassive (intermediate-risk) | Breathlessness, fast heart rate, right heart strain | 20 to 25 percent | Roughly 3 to 10 percent |
| Low-risk | Pleuritic pain, mild dyspnea, normal vitals | 60 to 75 percent | Under 2 percent |
| Incidental | None; found on scan ordered for another reason | Variable | Depends on clot burden |
| Chronic thromboembolic | Progressive breathlessness over months | Rare after acute event | Variable |
The table explains a paradox. Most embolisms are survivable, yet the condition is feared because a minority present with collapse. The task of symptom recognition is to catch the large middle group before it becomes the top row.
The time course: why minutes and days both matter
Pulmonary embolism does not unfold on a single clock. The timeline below reflects the biology of a clot forming, traveling, lodging, and resolving under treatment. Actual patient courses vary widely.
| Time from onset | What is happening | What may be felt |
|---|---|---|
| Hours to days before | Deep vein thrombosis forms in a leg or pelvis | Calf pain, swelling, warmth; often silent |
| Seconds to minutes | Clot dislodges and travels to the lung | Sudden dyspnea, chest pain, sometimes syncope |
| Minutes to hours | Right ventricular strain develops | Tachycardia, anxiety, hypotension in severe cases |
| 24 to 72 hours | Lung infarction may develop | Pleuritic pain, low-grade fever, hemoptysis |
| Days 3 to 7 | Clot begins to organize and shrink | Gradual improvement on anticoagulation |
| Weeks 1 to 4 | Most clot burden resolves | Residual dyspnea may persist |
| Months 3 to 6 | Symptom resolution expected in most | Persistent dyspnea suggests chronic disease |
| Beyond 6 months | Minority develop chronic thromboembolic disease | Progressive exertional breathlessness |
The counterintuitive point sits in the first row. The dangerous event is often the silent one. Deep vein thrombosis causes no symptoms in a large share of cases, so the first clinical signal may be the embolism itself. Roughly half of people with confirmed pulmonary embolism have no identifiable leg symptoms at presentation.
The presentations that fool clinicians
Textbook symptoms are a minority experience. Many confirmed embolisms are found in patients who look unremarkable, which is why risk scoring, not gestalt, drives testing.
Pleuritic pain, sharp and worse on inspiration, misleads toward pneumonia or pleurisy when fever and cough coexist. The combination of low-grade fever and a lung infiltrate on X-ray can appear in both conditions. Embolism does not respect that dichotomy.
Syncope, a brief loss of consciousness, appears in roughly 10 to 15 percent of cases and signals hemodynamic compromise. Treating it as a benign faint can delay imaging critically. Any syncope in a person with risk factors deserves consideration of embolism.
The chronic form is the subtlest. Untreated or incompletely resolved clots can organize into scar tissue inside pulmonary arteries, producing chronic thromboembolic pulmonary hypertension. This presents as progressive exertional breathlessness over months, often mistaken for deconditioning or asthma.
A professional caveat worth stating plainly: normal oxygen saturation does not exclude pulmonary embolism. Young patients can maintain saturation until right heart failure is advanced. Pulse oximetry is a clue, not a gate.
Risk factors, compared honestly
Risk is not a single trait but a stack of conditions that alter the balance between clotting and bleeding. Some are transient, some permanent. The table compares the main categories.
| Risk category | Examples | Approximate risk multiplier | Modifiable? |
|---|---|---|---|
| Major surgery or trauma | Hip or knee replacement, major abdominal surgery | Several-fold to more than 10-fold, highest in the first weeks | Timing partially controllable |
| Immobility | Long flights over 8 hours, bed rest, casting | Roughly 2 to 3 times | Yes, via movement and prophylaxis |
| Active cancer | Especially pancreatic, lung, and brain cancers | 4 to 7 times | Through cancer treatment |
| Estrogen exposure | Combined oral contraceptives, hormone therapy | 2 to 4 times | Yes, with clinician guidance |
| Prior venous thromboembolism | Previous deep vein thrombosis or embolism | High recurrence risk | Partly, via anticoagulation duration |
| Inherited thrombophilia | Factor V Leiden, prothrombin mutation | Modest to several-fold | Not modifiable |
| Pregnancy and postpartum | Especially the first six weeks after delivery | 4 to 5 times during pregnancy, higher postpartum | Managed with clinician guidance |
Exact multipliers vary by study population, so treat these as order-of-magnitude context rather than personal probabilities. The practical use is stacking awareness, not arithmetic.
A red-flag list belongs here. Seek emergency care immediately if any of these appear in combination with risk factors:
Sudden shortness of breath with chest pain or a racing heart. Fainting or near-fainting, especially with exertion. Coughing up blood. One-sided leg swelling with pain or redness. New breathlessness after surgery, hospitalization, or a long flight. Chest pain that does not ease and is worse on deep breathing.
What to actually do with a suspicion
The practical actions below reflect standard clinical pathways, not a self-diagnosis protocol. They are framed this way deliberately, because acting on a pulmonary embolism alone is unsafe.
First, call emergency services rather than driving yourself if symptoms are sudden and severe. The condition can deteriorate within minutes, and prehospital teams can begin monitoring and oxygen.
Second, tell responders and clinicians the entire risk picture. Recent surgery, cancer history, estrogen use, previous clots, and immobility are the details that change the testing threshold.
Third, expect a defined workup. The standard starts with pretest probability scoring, often the Wells criteria, followed by a D-dimer blood test in low-probability cases. D-dimer is a breakdown product of fibrin; a result below the age-adjusted threshold, generally defined as age times 10 micrograms per liter for patients over 50, makes embolism unlikely in low-risk patients. A positive D-dimer is nonspecific and requires imaging.
Fourth, confirm the diagnosis. Computed tomography pulmonary angiography is the standard imaging test for most stable patients. Ventilation-perfusion scanning or lower-limb ultrasound are alternatives in defined situations, such as kidney impairment or pregnancy, where contrast or radiation considerations differ.
The thresholds reconcile simply. D-dimer has high sensitivity and low specificity, so it rules out in low-probability patients and never rules in. Imaging carries high specificity and is reserved for patients who screen positive or already have high pretest probability. That sequencing is the whole puzzle.
Where the guidelines disagree and what is honestly unknown
Several genuine disputes remain. Guidelines from major societies differ on how aggressively to image low-probability patients with slightly elevated D-dimer. Some incorporate age-adjusted cutoffs broadly; others restrict them to specific probability tiers. The net effect is more imaging versus more false positives, and neither side claims certainty.
Sex-specific D-dimer thresholds are another unsettled area. Because D-dimer runs higher in older adults and in pregnancy, threshold adjustments are actively debated. Clinicians should state which threshold they applied, because a value near the cutoff can flip management.
The main limitation of this explainer is that symptom recognition alone cannot diagnose pulmonary embolism. The condition overlaps with pneumonia, heart failure, asthma, anxiety, and musculoskeletal pain. Every symptom list, including this one, has a false-negative rate that matters more than its positive predictive value.
A final caution concerns prognosis estimates. The mortality figures cited earlier come from cohorts spanning decades during which imaging, anticoagulants, and care pathways changed. Modern mortality in low-risk groups is lower than older numbers suggest. Presenting any figure as a current, personalized probability would overstate certainty.
For educational purposes only. This article is not medical advice and cannot diagnose or rule out pulmonary embolism; no outcome is promised or guaranteed. If you have chest pain, sudden breathlessness, fainting, or coughing up blood, call 911 or your local emergency number immediately rather than waiting. For non-urgent concerns and personal risk assessment, consult a qualified physician.